Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d‘Etude des Lymphomes Folliculaires
- 30 June 2004
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 126 (3) , 364-371
- https://doi.org/10.1111/j.1365-2141.2004.05046.x
Abstract
Summary: The influence of bone marrow biopsy (BMB) histology on prognosis and management of follicular lymphomas (FL) remains controversial. A total of 390 patients with grade 1 or 2 FL were prospectively included in the multicentric Groupe d'Etude des Lymphomes Folliculaires trial and their BMB reviewed in order (i) to quantify the ratio of lymphomatous foci (LFo) area to that of BMB size (LFo/BMB), (ii) to determine the BMB patterns for a practical grading of marrow infiltration, (iii) to assess the intra‐ and inter‐observer reproducibility of this grading and (iv) to analyse this grading on event‐free (EFS) and overall survival (OS), using univariate and multivariate analyses. A total of 267 patients (68%) had BMB involvement, with inter‐ and intra‐observer reproducibility for classifying the patterns of involvement of 91 and 96%, respectively. Uni‐ and multivariate analyses demonstrated the adverse influence of (i) a ratio of LFo/BMB ≥0·1, i.e. three or four nodules/medullary space or ≥1 nodule + foci of diffuse involvement on EFS (P = 0·03) and (ii) two different histological patterns in the same BMB on EFS (P = 0·004) and OS (P = 0·001). This latter finding was only significant in patients with a high tumour burden and remained significant in multivariate analysis. These results indicate that BMB histology can predict survival of FL patients with a high tumour burden, and may help in defining their treatment.Keywords
This publication has 23 references indexed in Scilit:
- Follicular Pattern of Bone Marrow Involvement by Follicular LymphomaAmerican Journal of Clinical Pathology, 2002
- Reliability of lymphoma classification in bone marrow trephinesBritish Journal of Haematology, 2002
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.Journal of Clinical Oncology, 1998
- Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular LymphomaNew England Journal of Medicine, 1993
- Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 yearsAnnals of Oncology, 1991
- Natural history of stage A chronic lymphocytic leukaemia untreated patientsBritish Journal of Haematology, 1990
- Treatment of low‐grade non‐Hodgkin's lymphomas: Assessment of doxorubicin in a controlled trialHematological Oncology, 1990
- Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management.Radiology, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958